Extended clopidogrel monotherapy versus DAPT in high-risk patients: the OPT-BIRISK trial
28 August 2023 (11:15 - 11:25)
Organised by: 
About the speaker
General Hospital of Northern Theater Command, Shenyang (China)
8 More presentations in this session
Access the full session
The Event
ESC Congress 2023
28 August 2023
11:15 CET
You may be interested in
Congress Presentation
Congress Presentation
